Irvine-based Edwards Lifesciences Corp. expects revenue next year to rise 8% to 10%, the heart valve maker said during a meeting with analysts Wednesday.
Edwards said it expected its 2006 sales to be $1.02 billion to $1.06 billion, slightly lower than Wall Street expectations, according to Thomson Financial. The company also reaffirmed its sales estimate of $1 billion for 2005.
On the profit front, Edwards projected earnings growth of 12% to 15% for 2006. Profit in 2005 is seen rising 18%.
Shares of Edwards were closed at $40 on Wednesday. The company saw its stock fall to a 10-month low of $39.85 on Tuesday.
Edwards’ shares have slumped this year amid come difficulty with trials of its minimally invasive heart-valve procedure.
